By late 2025, 12% of U.S. adults use GLP-1 drugs for diabetes or weight loss. Insurance coverage for weight-loss use varies, with most Marketplace plans and Medicare Part D excluding it. Costs range from $350 to $1,300 monthly, and some assistance programs exist. Medicaid and employer coverage differ by state and plan.
Continue to full article

Leave a Reply